上海皓元医药股份有限公司2025年第五次临时股东会决议公告

Meeting Overview - The fifth temporary shareholders' meeting of Shanghai Haoyuan Pharmaceutical Co., Ltd. was held on September 16, 2025 [2] - The meeting took place at the company's conference room located at 1999 Zhangheng Road, Pudong New District, Shanghai [2] - The total number of shares as of the registration date was 212,098,765, with 210,011,862 shares having voting rights after excluding employee stock plan shares [2] Voting and Attendance - The meeting was chaired by Chairman Zheng Baofu, and the voting method combined on-site and online voting [3] - All 7 current directors attended the meeting, with two participating via communication means [4] - The company’s board secretary and other executives were present, along with a witnessing lawyer [4] Resolutions - A key resolution regarding the change of the company's registered capital and the amendment of the Articles of Association was approved [5] - This resolution required a two-thirds majority of the voting rights held by shareholders present at the meeting [6] Legal Compliance - The meeting was witnessed by DeHeng Law Firm, confirming that the procedures followed were in compliance with the Company Law and other relevant regulations [6]